Stephen Basil Thomas Eliem Therapeutics, Inc. (ELYM) insider trading activity

ELYM Quotes by TradingView

Stephen Basil Thomas is of Eliem Therapeutics, Inc.. Currently has a direct ownership of 304,657 shares of ELYM, which is worth approximately $1.25 Million. The most recent transaction as insider was on Aug 07, 2025, when has been sold 100,375 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 305K
70.02% 3M change
193.2% 12M change
Total Value Held $1.25 Million

Stephen Basil Thomas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2025
BUY
Grant, award, or other acquisition
-
100,375 Added 24.78%
304,657 Common Stock
Jun 27 2025
BUY
Exercise of conversion of derivative security
-
25,094 Added 10.94%
204,282 Common Stock
Mar 27 2025
BUY
Exercise of conversion of derivative security
-
25,093 Added 12.28%
179,188 Common Stock
Jan 01 2025
BUY
Exercise of conversion of derivative security
-
50,188 Added 24.57%
154,095 Common Stock
Jun 27 2024
BUY
Grant, award, or other acquisition
-
103,907 Added 50.0%
103,907 Common Stock
SBT

Stephen Basil Thomas

Wilmington, DE

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELYM